U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243067) titled 'Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer' on Nov. 14.
Brief Summary: This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively collect blood specimens pre and post nephrectomy.
Study Start Date: Jan. 15, 2026
Study Type: OBSERVATIONAL
Condition:
Renal Cell Carcinoma
Clear-cell Renal Cell Carcinoma
Papillary Renal Cell Carcinoma
Chromopho...